Addressing global vaccine manufacturing to prepare for future disease outbreaks hosted by NCSU Biopharmaceutical Manufacturing Interest Group
Speaker: Dr. Matthew Downham, Sustainable Manufacturing Lead, Coalition for Epidemic Preparedness Innovations (CEPI)
Learn more about global challenges associated with COVID-19 vaccine manufacturing and distribution; the roles of organizations like COVAX and CEPI in improving global COVID-19 vaccine distribution; and governance issues that influence manufacturing challenges.
Dr. Downham completed a BSc Hons in Industrial Biology (South Bank Polytechnic London, UK inc. placement at Boehringer Mannheim, DE), PhD in Biochemical Engineering (Birmingham University, UK), Post-doctoral fellowship in biomolecular sciences (Liverpool John Moores University, UK), PGCE (Bolton Institute, UK) and was an EU Registered Toxicologist 2010-18 (Royal Society of Biology, UK). He has worked in the biopharmaceutical industry since 1997 for Protherics (UK), Bavarian Nordic & Morphosys (Germany), Novartis Vaccines & Diagnostics (Italy), AstraZeneca (UK). Throughout this time Dr. Downham worked on pre-/early clinical development of vaccine, antibody or enzyme therapies for infectious, hypertension, inflammatory & oncology indications. From 2013-2020 he was AZ Associate Director Head of MSAT/R&D (Influenza Vaccines) and Scientific & Technical Affairs (Influenza & Covid-19 Vaccines). From 2017 Dr. Downham chaired the Vaccines Europe Influenza working group, was treasurer of the IFPMA Influenza Vaccine Supply international task force and Vice Chair of the IFPMA Convention on Biological Diversity working group. Since Jan 2021, Dr. Downham leads Sustainable Manufacturing for CEPI (London, UK).